Item: Natco Pharma Ltd.
Rating: 2.3
Author: Trendlyne Technical Rating

Fetching latest news from server

RESEARCH REPORTS

Accumulate: Natco Pharma Ltd.

See all reports for NATCOPHARM

Buy: Natco Pharma Ltd.

See all reports for NATCOPHARM

ALERTS

Nirmal Bang Institutional downgraded Natco Pharma Ltd. to Accumulate with a price target of 813.0 on 12 Nov, 2018.
Stock Price (757.00) crossed below 100 Day SMA (771.74) on 05 November, 2018
Stock Price (739.45) crossed above 30 Day SMA (731.36) on 30 October, 2018
Stock Price (757.80) crossed below 50 Day SMA (784.35) on 24 September, 2018
Stock Price (757.80) crossed below 150 Day SMA (786.33) on 24 September, 2018

More triggered alerts

CORPORATE ANNOUNCEMENTS

CORPORATE ACTIONS

Dividends
Splits

Ex-Date Dividend	Amount	Dividend Type	Record Date
Aug. 20, 2018	1.50	INTERIM	Aug. 21, 2018
Feb. 15, 2018	7.00	INTERIM	Feb. 17, 2018
Aug. 16, 2017	1.25	INTERIM	Aug. 18, 2017
Feb. 23, 2017	6.00	INTERIM	Feb. 27, 2017
Aug. 19, 2016	0.75	INTERIM	Aug. 22, 2016

Ex-Date Dividend	Old FV	New FV	Record Date
Nov. 26, 2015	10	2	-

Natco Pharma Ltd.

Analyst Rating

No of reports

12

Recommendation upgrades

1

Recommendation downgrade

2

Featured In Screens

11

Price to Book Value

4.40

Revenue Qtr Cr c

543.50 Cr

Net Profit Qtr Cr c

181.60 Cr

RSI

48.22

MFI

63.77

MACD

0.43

MACD signal

1.14

SMA 30

722.40

SMA 50

744.52

SMA 100

764.85

SMA 200

782.15

Promoter holding %

48.34

FII holding %

24.32

MF holding %

5.13

Institutional holding %

30.42

Poll

Popular on Trendlyne

Volume Shockers: Dr. Reddy's Labs gains, Jindal Stainless ...

Stock Screener: Companies that announced results in past ...

Central Bank versus Centre: All eyes on RBI ...

Performance review: Larsen & Toubro (L&T) sees growth ...